World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
12518
World Ranking
3617
National Ranking
41

Felipe García publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Felipe García sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 314 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Felipe García D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Felipe García sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Felipe García is a researcher affiliated with the University of Barcelona in Spain. Their academic work predominantly spans the fields of Medicine and Immunology and Microbiology, with a focus on infectious diseases, virology, epidemiology, neurology, and immunology as subfields of study.

Their research covers several main topics including:

  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • HIV/AIDS Research and Interventions
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments

Among Felipe García's recent publications are the following papers:

  • "Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study," 2020, Clinical Microbiology and Infection
  • "COVID-19 in patients with HIV: clinical case series," 2020, The Lancet HIV
  • "Overview of SARS-CoV-2 infection in adults living with HIV," 2021, The Lancet HIV
  • "Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study," 2020, AIDS
  • "Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study," 2021, The Lancet HIV

Frequent co-authors collaborating with Felipe García include:

  • Lorna Leal
  • Juan Ambrosioni
  • Berta Torres
  • Álex Soriano
  • Marta Bodro

Felipe García's work has been published frequently in the following venues:

  • Vaccines
  • Frontiers in Immunology
  • Infectious Diseases and Therapy
  • The Lancet HIV
  • Clinical Infectious Diseases

The scientific contribution of Felipe García shows an emphasis on the clinical and epidemiological aspects of HIV and COVID-19, exploring both infection dynamics and treatment-related outcomes across their body of work.

Best Publications

  • Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.

    Carolina Garcia-Vidal;Gemma Sanjuan;Estela Moreno-García;Pedro Puerta-Alcalde

  • COVID-19 in patients with HIV: clinical case series.

    Jose L Blanco;Juan Ambrosioni;Felipe Garcia;Esteban Martínez

  • Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.

    Felipe Garcia;Montserrat Plana;Carmen Vidal;Anna Cruceta

  • Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

    Annette Oxenius;David A. Price;Huldrych F. Günthard;Sara J. Dawson

  • Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.

    M. Bodí;A. Rodríguez;J. Solé-Violán;M. C. Gilavert

  • Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count

    Felipe García;Elisa de Lazzari;Montserrat Plana;Pedro Castro

  • Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes.

    Vanesa Gómez-Piña;Alessandra Soares-Schanoski;Alexandro Rodríguez-Rojas;Carlos del Fresno

  • A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.

    Felipe García;Nuria Climent;Alberto C. Guardo;Cristina Gil

  • The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

    Felipe Garcia;Montserrat Plana;Gabriel M. Ortiz;Sebastian Bonhoeffer

  • A prospective trial of structured treatment interruptions in human immunodeficiency virus infection

    Catherine Fagard;Annette Oxenius;Huldrych Günthard;Felipe Garcia

  • HIV and syphilis: when to perform a lumbar puncture.

    Agnès Libois;Stéphane De Wit;Bénédicte Poll;Felipe F. García

  • Therapeutic Immunization with Dendritic Cells Loaded with Heat-Inactivated Autologous HIV-1 in Patients with Chronic HIV-1 Infection

    Felipe García;Merylene Lejeune;Nuria Climent;Cristina Gil

  • Tumor Cells Deactivate Human Monocytes by Up-Regulating IL-1 Receptor Associated Kinase-M Expression via CD44 and TLR4

    Carlos del Fresno;Karel Otero;Lourdes Gómez-García;Maria Carmen González-León

  • Plasma Stromal Cell–Derived Factor (SDF)-1 Levels, SDF1-3′A Genotype, and Expression of CXCR4 on T Lymphocytes: Their Impact on Resistance to Human Immunodeficiency Virus Type 1 Infection and Its Progression

    Alex Soriano;Catalina Martínez;Felipe García;Montserrat Plana

  • Incidence and causes of death in HIV‐infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area

    E Martínez;A Milinkovic;E Buira;E de Lazzari

  • Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease

    Montserrat Plana;Felipe Garcia;Teresa Gallart;José M Miró

  • A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection

    Felipe García;Núria Climent;Lambert Assoumou;Cristina Gil

  • A nosocomial outbreak of influenza during a period without influenza epidemic activity.

    J P Horcajada;T Pumarola;J A Martínez;G Tapias

  • Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.

    Richard B. Pollard;Jürgen K. Rockstroh;Giuseppe Pantaleo;David M. Asmuth

  • Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study.

    Alexy Inciarte;Ana Gonzalez-Cordon;Jhon Rojas;Berta Torres

Frequent Co-Authors

José M. Gatell
José M. Gatell University of Barcelona
José M. Miró
José M. Miró University of Barcelona
Tomás Pumarola
Tomás Pumarola Vall d'Hebron Institut de Recerca
Josep Mallolas
Josep Mallolas University of Barcelona
José Alcamí
José Alcamí Instituto de Salud Carlos III
Alex Soriano
Alex Soriano University of Barcelona
Javier Martinez-Picado
Javier Martinez-Picado University of Vic - Central University of Catalonia
Mariano Esteban
Mariano Esteban Spanish National Research Council
Josep Mensa
Josep Mensa University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, complementary careers in healthcare often begin with foundational nursing degrees. Many students choose accelerated pathways to fast-track their education, such as accelerated np programs, which offer a quicker transition to advanced practice roles like Nurse Practitioner.

For individuals without a nursing background, 12-month accelerated nursing programs online for non nurses provide an effective route to enter nursing swiftly, allowing them to build credentials that complement immunology expertise in clinical settings.

Many prospective students face competitive admissions, making it valuable to explore options such as the easiest accelerated nursing programs to get into, which can reduce entry barriers while still delivering quality education and clinical experience.

Additionally, for those looking for the fastest way to enter the healthcare workforce, fastest and easiest lpn programs offer practical, entry-level licenses that serve as a foundation for further specialization or career advancement related to immunology and patient care.

Best Scientists Citing Felipe García

Trending Scientists

Recently Published Articles